We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GNLN:NASDAQGreenlane Holdings, Inc. Analysis

Data as of 2026-05-19 - not real-time

$3.61

Latest Price

9/10Risk

Risk Level: High

Executive Summary

The stock trades at $3.61, just above the computed support of $3.60 and well below the 20‑day SMA of $4.54, indicating limited upside in the near term. Technicals show a bearish MACD (line below signal) and a neutral trend with RSI at 42, suggesting neither oversold nor overbought conditions. Volume is decreasing and beta is nearly 3, amplifying the 232% 30‑day volatility and pointing to a highly speculative price action. Fundamental metrics are distressed: revenue plunged 70%, operating margin is –12.4%, and EPS is deeply negative, while the price‑to‑book ratio of 0.03 implies the market values the company at a fraction of its book value.
Despite the weak operating results, the DCF model estimates a fair value of $27, implying a >600% upside from current levels, and the firm has recently regained Nasdaq compliance and is pursuing a digital‑asset treasury strategy that could unlock new revenue streams. However, regulatory exposure in both tobacco and crypto, the absence of any dividend, and a market cap of only $2.3 M heighten liquidity and sector risks. Investors should weigh the speculative upside against the extreme volatility and near‑zero earnings before taking a position.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Price hovering at support with bearish MACD
  • Extreme 30‑day volatility and high beta
  • Decreasing volume indicating waning buying interest

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Regained Nasdaq compliance reduces immediate delisting risk
  • Potential upside from digital‑asset strategy
  • Continued earnings deficits and weak cash flow

Long Term

> 3 years
Positive
Model confidence: 4/10

Key Factors

  • DCF fair value suggests >600% upside
  • Low price‑to‑book ratio indicating deep discount to assets
  • Strategic pivot to blockchain could create new revenue streams

Key Metrics & Analysis

Financial Health

Revenue Growth-69.50%
P/E Ratio-0.7
ROE-272.88%
ROA-71.83%
P/B Ratio0.0
Op. Cash Flow$-17645000
Free Cash Flow$289.1K

Technical Analysis

TrendNeutral
RSI41.8
Support$3.60
Resistance$7.06
MA 20$4.54
MA 50$4.48
MA 200$17.13
MACDBearish
VolumeDecreasing
Fear & Greed Index89.61

Valuation

Fair Value$27.11
GradeUndervalued
TypeValue

Risk Assessment

Beta2.94
Volatility232.48%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.